Skip to main content

Natazia FDA Approval History

FDA Approved: Yes (First approved May 6, 2010)
Brand name: Natazia
Generic name: dienogest and estradiol valerate
Previous Name: Qlaira
Company: Bayer HealthCare Pharmaceuticals Inc.
Treatment for: Birth Control

Natazia (dienogest and estradiol valerate) is a combination oral contraceptive indicated for use by women to prevent pregnancy and to treat heavy menstrual bleeding.

Development timeline for Natazia

DateArticle
Mar 15, 2012Approval U.S. FDA Approves First and Only Oral Contraceptive Demonstrated to Treat Heavy Menstrual Bleeding (HMB)
May  7, 2010Approval FDA Approves Natazia - New Combination Product Oral Contraceptive
Jul  8, 2009Bayer submits first-in-class estradiol-based oral contraceptive for approval in the U.S.

See also

Natazia (dienogest and estradiol valerate) Consumer information

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer